Browse hierarchy: [Anesthesiology (AN)](/submissions/AN) → [Subpart B — Diagnostic Devices](/submissions/AN/subpart-b%E2%80%94diagnostic-devices) → [21 CFR 868.1505](/submissions/AN/subpart-b%E2%80%94diagnostic-devices/868.1505) → QEB — Ventilatory Electrical Impedance Tomograph

# QEB · Ventilatory Electrical Impedance Tomograph

_Anesthesiology · 21 CFR 868.1505 · Class 2_

**Canonical URL:** https://fda.innolitics.com/submissions/AN/subpart-b%E2%80%94diagnostic-devices/QEB

## Overview

- **Product Code:** QEB
- **Device Name:** Ventilatory Electrical Impedance Tomograph
- **Regulation:** [21 CFR 868.1505](/submissions/AN/subpart-b%E2%80%94diagnostic-devices/868.1505)
- **Device Class:** 2
- **Review Panel:** [Anesthesiology](/submissions/AN)

## Identification

A ventilatory electrical impedance tomograph is a prescription non-invasive, non-radiological ventilatory device that provides an assessment of local impedance variation within a cross-section of a patient's thorax.

## Classification Rationale

Class II (special controls). The special controls for this device are:

## Special Controls

In combination with the general controls of the FD&C Act, the ventilatory electrical impedance tomograph is subject to the following special controls:

*Classification.* Class II (special controls). The special controls for this device are:(1) The patient-contacting components of the device must be demonstrated to be biocompatible.
(2) Non-clinical performance testing must demonstrate that the device performs as intended under anticipated conditions of use, including the following:
(i) Characterization of device parameters, including signal-to-noise ratio, voltage accuracy, drift, reciprocity accuracy, amplitude response, position error, and ringing;
(ii) Real time evaluation of local impedance variation;
(iii) Plethysmogram accuracy testing; and
(iv) Use life testing of reusable components.
(3) Performance data must validate reprocessing instructions for any reusable components of the device.
(4) Performance data must demonstrate the electrical, thermal, and mechanical safety and the electromagnetic compatibility of the device.
(5) Software verification, validation, and hazard analysis must be performed.
(6) Labeling must include the following:
(i) Guidance for interpretation of the images generated;
(ii) A warning that the device should be removed before use of a defibrillator, or defibrillator interaction information based on defibrillator performance testing with the device;
(iii) A use life for any reusable components; and
(iv) Instructions for reprocessing any reusable components.

## Recent Cleared Devices (6 of 6)

| Record | Device Name | Applicant | Decision Date | Decision |
| --- | --- | --- | --- | --- |
| [K250464](https://fda.innolitics.com/submissions/AN/subpart-b%E2%80%94diagnostic-devices/QEB/K250464.md) | Enlight 2100 (TPL-E2103-0) | Timpel S.A. | Sep 10, 2025 | SESE |
| [K243765](https://fda.innolitics.com/submissions/AN/subpart-b%E2%80%94diagnostic-devices/QEB/K243765.md) | LuMon(TM) System | Sentec AG | Aug 7, 2025 | SESE |
| [K222466](https://fda.innolitics.com/submissions/AN/subpart-b%E2%80%94diagnostic-devices/QEB/K222466.md) | AirTom | Bilab | Jun 30, 2023 | SESE |
| [K222897](https://fda.innolitics.com/submissions/AN/subpart-b%E2%80%94diagnostic-devices/QEB/K222897.md) | Enlight 2100 | Timpel S.A. | Mar 7, 2023 | SESE |
| [K211135](https://fda.innolitics.com/submissions/AN/subpart-b%E2%80%94diagnostic-devices/QEB/K211135.md) | Enlight 2100 | Timpel S.A. | Jan 6, 2022 | SESE |
| [DEN170072](https://fda.innolitics.com/submissions/AN/subpart-b%E2%80%94diagnostic-devices/QEB/DEN170072.md) | Enlight 1810 | Timpel, Inc. | Dec 20, 2018 | DENG |

## Top Applicants

- Timpel S.A. — 3 clearances
- Bilab — 1 clearance
- Sentec AG — 1 clearance
- Timpel, Inc. — 1 clearance

---

**Source:** [https://fda.innolitics.com/submissions/AN/subpart-b%E2%80%94diagnostic-devices/QEB](https://fda.innolitics.com/submissions/AN/subpart-b%E2%80%94diagnostic-devices/QEB)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com